Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of open-angle glaucoma and other diseases of the eye. The company has an approved product, Rhopressa? and advanced-stage product candidate, Roclatan?, which both are designed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company is also developing two preclinical sustained-release implants focused on retinal diseases, which include AR-13503 for the treatment of wet age-related macular degeneration and related diseases of the retina; and AR-1105, a preclinical dexamethasone steroid implant.

Associated Capital Group provides alternative investment management services and institutional research services, as well as management of its proprietary investment portfolio. In its alternative asset management operations, subsidiaries of the company serve as general partner or investment manager to investment funds including limited partnerships, offshore companies and separate accounts. The company primarily manages assets in equity event-driven value strategies, across a range of risk and event arbitrage portfolios. Also, the company provides institutional research services through its subsidiary, G.research, LLC, which is a broker-dealer and also acts as an underwriter primarily for the company's affiliates.

At Home Group is a holding company. Through its subsidiaries, the company is a home decor superstore. The company's product mix includes home furnishings, which consists of accent furniture, furniture, mirrors, patio cushions, rugs and wall art. Accent decor consists of artificial flowers and trees, bath, bedding, candles, garden and outdoor decor, holiday accessories, home organization, pillows, pottery, vases and window treatments. The company operates its stores primarily in the South Central, Southeastern, Mid-Atlantic and Midwestern regions of the U.S. In addition, the company operates a distribution center and warehouse premises in Texas, which services its stores, and a second distribution center in Pennsylvania.

Cloudera is an enterprise data cloud company. The company has multi-function data management and analytics software, including flow management, streams management, data engineering, data warehousing, streaming analytics, operational databases and machine learning. The company provides software subscriptions and public cloud services for the Cloudera Data Platform solution-set and software subscriptions for its on-premises data platforms. Subscriptions include software access rights and technical support. The company also provides services for the implementation and use of its software subscriptions, machine learning solutions and consultation, training and education services.

Comfort Systems USA provides mechanical contracting services, which include heating, ventilation and air conditioning (HVAC), plumbing, piping and controls, as well as off-site construction, electrical, monitoring and fire protection. The company provides construction, renovation, expansion, maintenance, repair and replacement services for mechanical and related systems in commercial, industrial and institutional properties. The company's installation business related to newly constructed facilities involves the design, engineering, integration, installation and start-up of mechanical and related systems. The company also provides remote monitoring of temperature, pressure, humidity and air flow for HVAC systems.

Coty and its subsidiaries are a beauty company. The company manufactures, markets, sells and distributes beauty products, including fragrances, color cosmetics, hair care products and skin and body related products. The company is organized into three divisions, which is also its operating and reportable segments: Consumer Beauty, Luxury and Professional Beauty. Consumer Beauty is primarily focused on color cosmetics, retail hair coloring and styling products, body care and mass fragrances. Luxury is primarily focused on fragrances, skincare and cosmetics. Professional Beauty is primarily focused on hair and nail care products for salon personnel.

GlycoMimetics is a clinical stage biotechnology company focused on the discovery and development of glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a main role. The company is developing uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia and other hematologic cancers. The company is also developing an additional drug candidate, GMI-1359, that simultaneously targets both E-selectin and a chemokine receptor known as CXCR4.

Green Dot is a bank holding company. Through its subsidiaries, the company provides a collection of banking and financial services products marketed directly to consumers through its banking platforms. The company's reportable segments include: Account Services, which provides several deposit account programs that can be acquired through its omni-channel branchless distribution platform, including consumer and small business checking account products, network-branded reloadable prepaid debit cards and secured credit programs; and Processing and Settlement Services, which provides several products and services that engage in facilitating the movement of funds on behalf of consumers and businesses.

Marrone Bio Innovations makes bio-based pest management and plant health products. Bio-based products are comprised of naturally occurring microorganisms, such as bacteria and fungi, and plant extracts. The company primarily sells its products to the crop protection market and also have one plant health product, Haven, that reduces plant stress in drought and intense sunlight. The company's product lines are Regalia, for controlling plant disease and increasing plant health, Grandevo and Venerate, for insect and mite control, Majestene and its turf and ornamentals counterpart brand Zelto, for nematode control and Stargus and its row crop counterpart brand Amplitude, for downy mildew and white mold control.

Nektar Therapeutics is a research-based biopharmaceutical company. The company's proprietary drugs and drug candidates that have either received regulatory approval or are being developed by the company or in collaboration with other pharmaceutical companies or independent investigators include: ONZEALD?, a topoisomerase I inhibitor targeted for advanced metastatic breast cancer in patients with brain metastases; NKTR-181, an orally-available mu-opioid analgesic molecule for moderate to severe chronic pain; NKTR-214, a CD122-biased immune-stimulatory cytokine targeted for oncology; NKTR-358 for autoimmune disease; NKTR-262 targeted for solid tumors; and NKTR-255 targeted for immuno-oncology.

J. C. Penney Company is a holding company whose principal operating subsidiary is J. C. Penney Corporation, Inc. The company's business consists of selling merchandise and services to consumers through its department stores and its website at jcpenney.com. The company's department stores and website serve the same type of customers, its website provides the same mix of merchandise as its store assortment along with other extended categories that are not provided in store, and its department stores accept returns from sales made in stores and via its website. The company sells family apparel and footwear, accessories, jewelry, beauty products through Sephora inside JCPenney, and home furnishings.

Progenics Pharmaceuticals is an oncology company focused on the development and commercialization of medicines and artificial intelligence to find, fight and follow cancer. The company's product candidates include: AZEDRA, which is a radiotherapeutic for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy; and PyL?, which is a fluorinated prostate-specific membrane antigen-targeted PET imaging agent that enables visualization of both bone and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer.

Unifi manufactures and sells recycled and synthetic products made from polyester and nylon primarily to other yarn manufacturers and knitters and weavers that produce yarn and/or fabric for the apparel, hosiery, home furnishings, automotive, industrial and other end-use markets. The company has four segments: Polyester, which sells polyester-based products to other yarn manufacturers, knitters and weavers that produce yarn and/or fabric; Nylon, which sells nylon-based products to knitters and weavers that produce fabric for the apparel and hosiery markets; and Brazil and Asia, which sells polyester-based products to knitters that produce fabric for the apparel markets in South America and in Asia.

Vapotherm is a medical technology company focused on the development and commercialization of its proprietary Hi-VNI Technology products that are used to treat patients of all ages suffering from respiratory distress. The company's Hi-VNI Technology delivers non-invasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a small-bore nasal interface. The company provides four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. The company's companion products include: Vapotherm Transfer Unit 2.0, the Q50 compressor, the aerosol aeroneb adaptor, and a tracheostomy adaptor.